Gryphon Financial Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.61M | Buy |
13,352
+1,627
| +14% | +$188K | 0.16% | 92 |
|
|
2025
Q4 | $1.23M | Buy |
11,725
+730
| +7% | +$68.5K | 0.13% | 101 |
|
|
2025
Q3 | $923K | Sell |
10,995
-985
| -8% | -$81.1K | 0.11% | 123 |
|
|
2025
Q2 | $948K | Sell |
11,980
-3,916
| -25% | -$311K | 0.12% | 111 |
|
|
2025
Q1 | $1.43M | Sell |
15,896
-938
| -6% | -$87.6K | 0.21% | 72 |
|
|
2024
Q4 | $1.67M | Buy |
16,834
+342
| +2% | +$35.3K | 0.24% | 57 |
|
|
2024
Q3 | $1.87M | Buy |
16,492
+760
| +5% | +$90.3K | 0.25% | 54 |
|
|
2024
Q2 | $1.95M | Buy |
15,732
+875
| +6% | +$113K | 0.29% | 46 |
|
|
2024
Q1 | $1.96M | Buy |
14,857
+927
| +7% | +$114K | 0.33% | 49 |
|
|
2023
Q4 | $1.44M | Buy |
13,930
+6,421
| +86% | +$667K | 0.25% | 57 |
|
|
2023
Q3 | $773K | Sell |
7,509
-238
| -3% | -$25.7K | 0.18% | 63 |
|
|
2023
Q2 | $894K | Sell |
7,747
-122
| -2% | -$13.9K | 0.19% | 63 |
|
|
2023
Q1 | $837K | Sell |
7,869
-217
| -3% | -$23.4K | 0.19% | 61 |
|
|
2022
Q4 | $897K | Buy |
8,086
+84
| +1% | +$8.59K | 0.21% | 59 |
|
|
2022
Q3 | $689K | Buy |
8,002
+1,712
| +27% | +$153K | 0.17% | 71 |
|
|
2022
Q2 | $574K | Sell |
6,290
-486
| -7% | -$43.1K | 0.14% | 85 |
|
|
2022
Q1 | $556K | Buy |
6,776
+105
| +2% | +$8.28K | 0.11% | 102 |
|
|
2021
Q4 | $512K | Buy |
6,671
+53
| +0.8% | +$4.22K | 0.1% | 125 |
|
|
2021
Q3 | $497K | Sell |
6,618
-666
| -9% | -$50.7K | 0.11% | 105 |
|
|
2021
Q2 | $583K | Buy |
7,284
+275
| +4% | +$20.5K | 0.13% | 78 |
|
|
2021
Q1 | $516K | Buy |
7,009
+42
| +0.6% | +$3.1K | 0.12% | 93 |
|
|
2020
Q4 | $543K | Sell |
6,967
-41
| -0.6% | -$3.14K | 0.14% | 81 |
|
|
2020
Q3 | $554K | Buy |
7,008
+151
| +2% | +$11.8K | 0.16% | 68 |
|
|
2020
Q2 | $506K | Sell |
6,857
-46
| -0.7% | -$3.46K | 0.16% | 66 |
|
|
2020
Q1 | $506K | Buy |
6,903
+24
| +0.3% | +$1.89K | 0.19% | 58 |
|
|
2019
Q4 | $597K | Sell |
6,879
-39
| -0.6% | -$3.2K | 0.15% | 72 |
|
|
2019
Q3 | $556K | Buy |
6,918
+173
| +3% | +$13.9K | 0.16% | 72 |
|
|
2019
Q2 | $539K | Sell |
6,745
-255
| -4% | -$19.5K | 0.16% | 73 |
|
|
2019
Q1 | $556K | Buy |
7,000
+77
| +1% | +$5.76K | 0.16% | 69 |
|
|
2018
Q4 | $505K | Buy |
6,923
+161
| +2% | +$11.4K | 0.13% | 117 |
|
|
2018
Q3 | $458K | Buy |
6,762
+2,691
| +66% | +$171K | 0.14% | 87 |
|
|
2018
Q2 | $235K | Sell |
4,071
-242
| -6% | -$13.7K | 0.11% | 71 |
|
|
2018
Q1 | $224K | Sell |
4,313
-7
| -0.2% | -$378 | 0.11% | 74 |
|
|
2017
Q4 | $232K | Buy |
+4,320
| New | +$239K | 0.13% | 74 |
|
Other funds holding MRK
VCM
VPM
Gryphon Financial Partners's MRK Position: Q1 2026 in Review
Gryphon Financial Partners increased its Merck (MRK) stake by 14% in Q1 2026, buying an estimated $188K and bringing the position to 13,352 shares worth $1.61M. The position accounts for 0.16% of the portfolio, ranked #92.
Gryphon Financial Partners first reported a position in MRK in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.96M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Gryphon Financial Partners held 13,352 shares of Merck worth $1.61M as of Q1 2026.
- Gryphon Financial Partners bought 1,627 Merck shares in Q1 2026, an estimated $188K.
- Merck made up 0.16% of Gryphon Financial Partners's portfolio in Q1 2026, its #92 holding.
- Gryphon Financial Partners first reported a position in Merck in Q4 2017 and has held it in 34 quarters since.
- Gryphon Financial Partners's Merck position peaked at $1.96M in Q1 2024.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Gryphon Financial Partners's 13F filing for Q1 2026, filed 6 May 2026.